The global Personal Genome Testing Market is forecast to be appraised at USD 4,468 Million by 2032, up from USD 1,545.5 Million in 2022, advancing at a CAGR of 10.1% during the forecast period.
| Attributes | Details |
|---|---|
| Personal Genome Testing Market Size (2022) | USD 1,545.5 Million |
| Personal Genome Testing Market Size (2032) | USD 4,468 Million |
| Personal Genome Testing Market CAGR (2022 to 2032) | 10.1% |
The advancements in the field of genetic testing, along with its wide usage in pharmacogenomics and toxicogenomic, drives the demands for personal genome testing. Increasing deployment of paternity testing, maternity testing, and prenatal testing promotes personal genome testing market growth.
The increased and developing awareness among healthcare professionals regarding the efficacy of these diagnostics owing to strong testing volumes ordered and managed by non-geneticists surges the adoption of personal genome testing.
Lifestyle-based and nutrition-based genetic tests are widely available for aiding diet and lifestyle plans among consumers, increasing demand for personal genome testing. The accuracy and reliable technology of genetic testing, and the growing awareness about its benefits, propels the personal genome testing market share.
With the expansion of DTC genetic tests' application areas, the market share for personal genome testing increases. The market for personal genome testing is being expanded by businesses that provide DTC tests for use in continuing research, sports, nutrition, and other areas.
The range of services offered by genetic testing, such as data security, identification of ancestors, race and nature of family, increasing its usage in clinical practices, surges demand for personal genome testing.
The low cost value of genome testing across clinics, ranging from USD 99 to USD 2000, drives the demand for personal genome testing. Rising prevalence of genetic diseases related to genotype, phenotype, or mutation, and its need for detection and prevention propels the personal genome testing market growth.
The ability to detect genetic abnormalities in the early gestation period of 8 to 10 weeks surges the demand for personal genome testing. Growing R&D activities, along with government initiatives in the field, escalates the adoption of personal genome testing.
Increasing awareness and discoveries in the field of genetic testing, as well as the option to determine the sex of a fetus, broadens the personal genome testing market share. Descriptive information regarding analytical validity and clinical validity of the tests offered by the service provide, increases the demand for personal genome testing.
The requirement for identification and addressing of specific needs, personalized direct-to-consumer genetic tests, escalates the personal genome testing market size. Favorable reimbursement policies and increasing coverage for preventative genetic testing elevate the personal genome testing market share.
Due to the shortage of trained professionals, end users face significant issues in analyzing genomic data, hindering the personal genome testing market growth. Rigid regulatory requirements for product approvals are expected to hamper the demand for personal genome testing.
The personal genome testing market size is further obstructed owing to standardization concerns of genetic testing-based diagnostics.
Furthermore, the unavailability of doctors and genetic counselors, along with closing of test-running laboratories leading to disruption, limitation and challenges during the pandemic, hampered the adoption of personal genome testing.
Scepticism and criticism regarding genetic testing from healthcare professionals, owing to lack of evidence, thwarts the personal genome testing market share.
The desire for personal genome testing is curbed by the loss of discretion and control over customers' genetic material, as well as the risk that testing procedures could lead to a third party accessing clients' DNA information.
Unexplored emerging markets in developing economies and a high number of customers opting for online genetic testing are anticipated to promote the global personal genome testing market growth.
Moreover, the adoption of personal genome testing increases owing to the growth in the personalized medicine market, especially among the pharmaceutical companies. The shift of focus from clinical science to bioinformatics, and the increasing popularity of these techniques, increases the demand for personal genome testing.
Increased efficiency, accuracy, and new innovations and techniques further propel the demand for personal genome testing.
North America holds the leading position in the personal genome testing market share, with a revenue of 37.3%.
This is owing to the rise in cases of genetic diseases and an increasing demand for technologically advanced medical equipment for treatment. The availability of a substantial number of key players dealing with genetic tests in this region surges the demand for personal genome testing.
High awareness about at-home testing among the U.S. population promotes the global personal genome testing market growth.
Europe has the second leading personal genome testing market share, with a revenue share of 26%.
The rising demand for technologically advanced medical equipment for treatment in this region promotes personal genome testing market growth.
The presence of key players, as well as new players entering the market causing competition, secures the expansion of the personal genome testing market size.
Due to rising knowledge of the advantages of genetic testing, the personal genome testing market share is predicted to increase in Asia-Pacific. Personal genome testing is becoming more popular as a result of growing awareness of numerous genetic illnesses and an increase in their prevalence in this area.
Rapid development of healthcare infrastructures across Asian countries further promotes market growth.
Several market players, through research and development activities, are coming up with innovative strategies to refine genetic testing in clinics. They are also implementing schemes to protect the privacy of their clients’ DNA information.
Emerging players such as 3x4 Genetics, 3billion, CircaGene, Bione, Athletic Genetix, etc. are offering various services such as DNA-based fitness programs, genetic testing for rare diseases, personalized genetic test platforms, microbiome testing, genetic testing for athletes, etc.
Some of the key market participants in the personal genome testing market are 23andMe Inc., Navigenics, deCODEme, Color Genomics Inc., Personal Genome Diagnostics Inc., Counsyl, Inc., Quest Diagnostics, Gene By Gene Ltd., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., BGI, MYRIAD GENETICS, INC. (MYRIAD RBM, INC.), Eurofins Scientific, CSL Ltd., Abbott Laboratories, Invitae Corporation, Ambry Genetics, BioReference, Progenity Inc., and others are coming up with new innovations to perfect the extraction of genetic material.
Rising cases of chronic diseases are increasing the adoption of personal genome testing. This is attributed to the growth of key players in the market, which is increasing competitiveness in the market, surging the demand for personal genome testing.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 10.1% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Type, Application, and Region. |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | 23andMe Inc.; Navigenics; deCODEme; Color Genomics Inc.; Personal Genome Diagnostics Inc.; Counsyl, Inc.; Quest Diagnostics; Gene By Gene Ltd.; Laboratory Corporation of America Holdings; Thermo Fisher Scientific; QIAGEN N.V.; Agilent Technologies, Inc.; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories Inc.; BGI; MYRIAD GENETICS, INC. (MYRIAD RBM, INC.); Eurofins Scientific; CSL Ltd.; Abbott Laboratories; Invitae Corporation; Ambry Genetics; BioReference; Progenity Inc.; Burning Rock Biotech Ltd.; Celera Group; PerkinElmer Inc.; Quest Diagnostics Inc.; ELITech Group; Roche Diagnostics Corp.; Applied Biosystems Inc.; Roche Molecular Diagnostics Inc.; Transgenomic Inc.; Color Genomics; EasyDNA; Family Tree DNA; Full Genome Corporation Inc.; Helix OpCo LLC; Karmagenes SA; Living DNA Ltd.; MyHeritage; 24 Genetics; The SkinDNA Company Pty Ltd; DNA Forensics Laboratory Pvt. Ltd. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Table 1: Global Personal Genome Testing Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 3: Global Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 4: North America Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 5: North America Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 6: North America Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 7: Latin America Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Latin America Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 9: Latin America Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 10: Europe Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 12: Europe Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 13: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 15: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 16: MEA Personal Genome Testing Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: MEA Personal Genome Testing Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 18: MEA Personal Genome Testing Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Figure 1: Global Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 2: Global Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 3: Global Personal Genome Testing Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Personal Genome Testing Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Personal Genome Testing Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Personal Genome Testing Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 8: Global Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 9: Global Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 10: Global Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 11: Global Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 12: Global Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 13: Global Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 14: Global Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 15: Global Personal Genome Testing Market Attractiveness by Region, 2022-2032
Figure 16: North America Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 17: North America Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 18: North America Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 23: North America Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 24: North America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 25: North America Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 26: North America Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 27: North America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 28: North America Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 29: North America Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 30: North America Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 32: Latin America Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 33: Latin America Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 38: Latin America Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 39: Latin America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 40: Latin America Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 41: Latin America Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 42: Latin America Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 43: Latin America Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 44: Latin America Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 45: Latin America Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 46: Europe Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 47: Europe Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 48: Europe Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 53: Europe Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 54: Europe Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 55: Europe Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 56: Europe Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 57: Europe Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 58: Europe Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 59: Europe Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 60: Europe Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 62: Asia Pacific Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 63: Asia Pacific Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: Asia Pacific Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 68: Asia Pacific Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 69: Asia Pacific Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 70: Asia Pacific Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 71: Asia Pacific Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 72: Asia Pacific Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 73: Asia Pacific Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 74: Asia Pacific Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 75: Asia Pacific Personal Genome Testing Market Attractiveness by Country, 2022-2032
Figure 76: MEA Personal Genome Testing Market Value (US$ Mn) by Application, 2022-2032
Figure 77: MEA Personal Genome Testing Market Value (US$ Mn) by Product Type, 2022-2032
Figure 78: MEA Personal Genome Testing Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA Personal Genome Testing Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: MEA Personal Genome Testing Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA Personal Genome Testing Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA Personal Genome Testing Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 83: MEA Personal Genome Testing Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 84: MEA Personal Genome Testing Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 85: MEA Personal Genome Testing Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 86: MEA Personal Genome Testing Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 87: MEA Personal Genome Testing Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 88: MEA Personal Genome Testing Market Attractiveness by Application, 2022-2032
Figure 89: MEA Personal Genome Testing Market Attractiveness by Product Type, 2022-2032
Figure 90: MEA Personal Genome Testing Market Attractiveness by Country, 2022-2032
Ans. Personal genome testing is likely to register a CAGR of 10.1% during the forecast period.
North America is the leading personal genome testing market, with a revenue share of 37.3%.
By 2032, the market is likely to grow to a valuation of USD 4,468 Million.
Explore Life Science & Biotechnology Insights
Personal Genome Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
